Related references
Note: Only part of the references are listed.Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
Gregory J. Wehner et al.
EUROPEAN HEART JOURNAL (2020)
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D. Solomon et al.
CIRCULATION (2020)
What do patients with heart failure die from? A single assassin or a conspiracy?
Markus S. Anker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry
Constantinos Ergatoudes et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
Giuseppe Vergaro et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death POST SCD Study
Zian H. Tseng et al.
CIRCULATION (2018)
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study
Annamaria Iorio et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Karen A. Hicks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg study
A. Andrea Pozzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Mode of Death in Heart Failure With Preserved Ejection Fraction
Muthiah Vaduganathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial
Scott D. Solomon et al.
JACC-HEART FAILURE (2017)
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D. Solomon et al.
EUROPEAN HEART JOURNAL (2016)
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model
Ramin Shadman et al.
HEART RHYTHM (2015)
How do patients with heart failure with preserved ejection fraction die?
Michelle M. Y. Chan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)